These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2749782

  • 1. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat.
    Jimmerson VR, Shih TM, Maxwell DM, Mailman RB.
    Toxicol Lett; 1989 Jul; 48(1):93-103. PubMed ID: 2749782
    [Abstract] [Full Text] [Related]

  • 2. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity.
    Maxwell DM, Brecht KM, O'Neill BL.
    Toxicol Lett; 1987 Nov; 39(1):35-42. PubMed ID: 3672554
    [Abstract] [Full Text] [Related]

  • 3. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM, Brecht KM, Lenz DE, O'Neill BL.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [Abstract] [Full Text] [Related]

  • 4. Role of aliesterase in organophosphate poisoning.
    Clement JG.
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S96-105. PubMed ID: 6724216
    [Abstract] [Full Text] [Related]

  • 5. Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice.
    Clement JG.
    Biochem Pharmacol; 1984 Dec 01; 33(23):3807-11. PubMed ID: 6508835
    [Abstract] [Full Text] [Related]

  • 6. Effects of CBDP and MEPQ on the toxicity and distribution of [3H]-soman in mice.
    Shapira S, Kadar T, Cohen G, Chapman S, Raveh L.
    Arch Toxicol; 1990 Dec 01; 64(8):663-8. PubMed ID: 2090035
    [Abstract] [Full Text] [Related]

  • 7. Stereoisomers of soman (pinacolyl methylphosphonofluoridate): inhibition of serum carboxylic ester hydrolase and potentiation of their toxicity by CBDP (2-(2-methylphenoxy)-4H-1,3,2-benzodioxaphosphorin-2-oxide) in mice.
    Clement JG, Benschop HP, DeJong LP, Wolthuis OL.
    Toxicol Appl Pharmacol; 1987 Jun 15; 89(1):141-3. PubMed ID: 3590185
    [Abstract] [Full Text] [Related]

  • 8. Role of carboxylesterase in soman, sarin and tabun poisoning in rats.
    Jokanović M.
    Pharmacol Toxicol; 1989 Sep 15; 65(3):181-4. PubMed ID: 2813290
    [Abstract] [Full Text] [Related]

  • 9. The effect of 2-(o-cresyl)-4H-1:3:2-benzodioxaphosphorin-2-oxide on tissue cholinesterase and carboxylesterase activities of the rat.
    Jimmerson VR, Shih TM, Maxwell DM, Kaminskis A, Mailman RB.
    Fundam Appl Toxicol; 1989 Oct 15; 13(3):568-75. PubMed ID: 2612789
    [Abstract] [Full Text] [Related]

  • 10. Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.
    Yang ZP, Dettbarn WD.
    Biochem Pharmacol; 1998 May 01; 55(9):1419-26. PubMed ID: 10076534
    [Abstract] [Full Text] [Related]

  • 11. Effect of pretreatment with CBDP on the toxicokinetics of soman stereoisomers in rats and guinea pigs.
    Due AH, Trap HC, Van Der Wiel HJ, Benschop HP.
    Arch Toxicol; 1993 May 01; 67(10):706-11. PubMed ID: 8135661
    [Abstract] [Full Text] [Related]

  • 12. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
    Maxwell DM, Koplovitz I.
    J Pharmacol Exp Ther; 1990 Aug 01; 254(2):440-4. PubMed ID: 2384881
    [Abstract] [Full Text] [Related]

  • 13. Hepatic subcellular localization of cresylbenzodioxaphosphorin oxide (CBDP)-sensitive soman binding sites.
    Little JS, Maxwell DM, Fox-Talbot MK, Brecht K, Lenz DE.
    Biochem Pharmacol; 1990 Oct 15; 40(8):1733-7. PubMed ID: 2242010
    [Abstract] [Full Text] [Related]

  • 14. Variability in soman toxicity in the rat: correlation with biochemical and behavioral measures.
    Jimmerson VR, Shih TM, Mailman RB.
    Toxicology; 1989 Aug 15; 57(3):241-54. PubMed ID: 2756526
    [Abstract] [Full Text] [Related]

  • 15. Role of carboxylesterase in protection against soman toxicity.
    Purshottam T, Srivastava R.
    Pharmacology; 1989 Aug 15; 38(5):319-26. PubMed ID: 2762374
    [Abstract] [Full Text] [Related]

  • 16. The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds.
    Maxwell DM.
    Toxicol Appl Pharmacol; 1992 Jun 15; 114(2):306-12. PubMed ID: 1609424
    [Abstract] [Full Text] [Related]

  • 17. Iso-OMPA-induced potentiation of soman toxicity in rat correlates with the inhibition of plasma carboxylesterases.
    Grubic Z, Sket D, Brzin M.
    Arch Toxicol; 1988 Jun 15; 62(5):398-9. PubMed ID: 3242452
    [Abstract] [Full Text] [Related]

  • 18. The role of carboxylesterase in species variation of oxime protection against soman.
    Maxwell DM, Brecht KM.
    Neurosci Biobehav Rev; 1991 Jun 15; 15(1):135-9. PubMed ID: 2052186
    [Abstract] [Full Text] [Related]

  • 19. A method for generating toxic vapors of soman: toxicity of soman by inhalation in rats.
    Aas P, Sterri SH, Hjermstad HP, Fonnum F.
    Toxicol Appl Pharmacol; 1985 Sep 30; 80(3):437-45. PubMed ID: 4035697
    [Abstract] [Full Text] [Related]

  • 20. The influence of 2-/o-cresyl/-4 H-1 : 3 : 2-benzodioxa-phosphorin-2-oxide (CBDP) on organophosphate poisoning and its therapy.
    Bosković B.
    Arch Toxicol; 1979 Jul 11; 42(3):207-16. PubMed ID: 475595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.